Jess Jankowski - 02 Nov 2022 Form 4/A - Amendment Insider Report for NANOPHASE TECHNOLOGIES Corp (SLSN)

Role
President, CEO, Director
Signature
Jess A. Jankowski
Issuer symbol
SLSN
Transactions as of
02 Nov 2022
Net transactions value
-$30,039
Form type
4/A - Amendment
Filing time
07 Nov 2022, 16:00:25 UTC
Date Of Original Report
04 Nov 2022
Previous filing
26 Oct 2022
Next filing
09 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NANX Common Stock Options Exercise $3,071 +7,400 +13% $0.4150 66,400 02 Nov 2022 Direct F1
transaction NANX Common Stock Sale $17,908 -7,400 -11% $2.42 59,000 02 Nov 2022 Direct
transaction NANX Common Stock Options Exercise $1,777 +4,283 +7.3% $0.4150 63,283 03 Nov 2022 Direct F1
transaction NANX Common Stock Sale $9,851 -4,283 -6.8% $2.30 59,000 03 Nov 2022 Direct
transaction NANX Common Stock Options Exercise $415 +1,000 +1.7% $0.4150 60,000 04 Nov 2022 Direct F1
transaction NANX Common Stock Sale $2,280 -1,000 -1.7% $2.28 59,000 04 Nov 2022 Direct
holding NANX Common Stock 1,000 02 Nov 2022 Spouse's IRA
holding NANX Common Stock 59,000 02 Nov 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NANX Common Stock (right to purchase) Options Exercise $3,071 -7,400 -8.5% $0.4150 79,300 02 Nov 2022 Common Stock 86,700 $0.4150 Direct F2
transaction NANX Common Stock (right to purchase) Options Exercise $1,777 -4,283 -5.4% $0.4150 75,017 03 Nov 2022 Common Stock 79,300 $0.4150 Direct F2
transaction NANX Common Stock (right to purchase) Options Exercise $415 -1,000 -1.3% $0.4150 74,017 04 Nov 2022 Common Stock 75,017 $0.4150 Direct F1
holding NANX Common Stock (right to purchase) 90,000 02 Nov 2022 Common Stock 90,000 $0.5200 Direct F3
holding NANX Common Stock (right to purchase) 81,000 02 Nov 2022 Common Stock 81,000 $0.4400 Direct F4
holding NANX Common Stock (right to purchase) 69,000 02 Nov 2022 Common Stock 69,000 $0.4200 Direct F4
holding NANX Common Stock (right to purchase) 81,000 02 Nov 2022 Common Stock 81,000 $0.6800 Direct F4
holding NANX Common Stock (right to purchase) 90,000 02 Nov 2022 Common Stock 90,000 $0.8200 Direct F5
holding NANX Common Stock (right to purchase) 16,500 02 Nov 2022 Common Stock 16,500 $0.5100 Direct F3
holding NANX Common Stock (right to purchase) 90,000 02 Nov 2022 Common Stock 90,000 $0.4500 Direct F3
holding NANX Common Stock (right to purchase) 90,000 02 Nov 2022 Common Stock 90,000 $4.17 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options are set to expire on 02/14/2023. Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors.
F2 These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker. His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors.
F3 Subject to certain restrictions, beginning on this date, options vest in three equal installments.
F4 Subject to certain restrictions, beginning on this date, the options vest in three equal annual installments.
F5 Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

Remarks:

This filing was amended to reflect the correction of an input error on the conversion of a stock option to common stock on November 4, 2022. The original filing listed the acquisition price of the shares at the sale price, instead of the strike price of the common stock option being exercised. The entry on the seventh line in Table I under "Price" was changed from $2.28 to $0.415 per share. Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having shares from this grant sold, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors. The maturity of these rights cannot be extended beyond the IRS statutory limit of ten years.